Thus, increased methylation of SGK2 may suppress abnormal cell growth in NAFLD as well as in viral and alcoholic hepatitis, while decreased methylation may facilitate cell growth and proliferation in HCC. The gene discussed is SGK2; the disease is metabolic dysfunction-associated steatotic liver disease.